• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性和非恶性口腔病变中的潜在组织病理学和免疫生物标志物。

Potential Histopathological and Immune Biomarkers in Malignant and Non-Malignant Oral Lesions.

作者信息

de Souza Vinícius Gonçalves, de Lourdes Carvalho Aparecida, Miranda Carla Silva Siqueira, Cardoso Ludimila Paula Vaz

机构信息

Medicine course, Federal University of Jataí, JataíBrazil.

出版信息

J Oral Maxillofac Res. 2022 Dec 31;13(4):e3. doi: 10.5037/jomr.2022.13403. eCollection 2022 Oct-Dec.

DOI:10.5037/jomr.2022.13403
PMID:36788796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9902024/
Abstract

OBJECTIVES

The presented case-control study was developed to characterize the clinical, histopathological and immunological profile of patients with traumatic injuries, benign neoplasms, potentially malignant oral disorders and malignant neoplasms of the oral cavity, in order to identify biomarkers of malignancy.

MATERIAL AND METHODS

Clinical information was collected from dental records and several techniques were performed, including histopathological evaluation in sections stained with haematoxylin and eosin, immunohistochemistry for programmed death ligand-1 and measurement of serum levels of interferon-gamma, interleukin-6, -10 and -12. Statistical analysis was performed using IBM SPSS Statistics software.

RESULTS

This study included 8 patients with traumatic injuries, 8 with benign neoplasms, 6 with potentially malignant oral disorders and 11 with malignant neoplasms. An association was observed between the classification of the lesion and smoking (P < 0.05), the size of the lesion (P < 0.05), the density of the inflammatory infiltrate (P < 0.001), the degree of dysplasia (P < 0.01) and programmed death ligand-1 expression (P < 0.01).

CONCLUSIONS

Therefore, it is suggested that smoking, the size of the lesion, the inflammatory infiltrate and the programmed death ligand-1 expression can be considered potential biomarkers of oral malignancy.

摘要

目的

开展本病例对照研究,以描述口腔创伤性损伤、良性肿瘤、潜在恶性口腔疾病及恶性肿瘤患者的临床、组织病理学和免疫学特征,从而确定恶性肿瘤的生物标志物。

材料与方法

从牙科记录中收集临床信息,并进行了多种技术检测,包括苏木精和伊红染色切片的组织病理学评估、程序性死亡配体-1的免疫组织化学检测以及血清γ-干扰素、白细胞介素-6、-10和-12水平的测定。使用IBM SPSS Statistics软件进行统计分析。

结果

本研究纳入8例创伤性损伤患者、8例良性肿瘤患者、6例潜在恶性口腔疾病患者和11例恶性肿瘤患者。观察到病变分类与吸烟(P < 0.05)、病变大小(P < 0.05)、炎症浸润密度(P < 0.001)、发育异常程度(P < 0.01)和程序性死亡配体-1表达(P < 0.01)之间存在关联。

结论

因此,提示吸烟、病变大小、炎症浸润和程序性死亡配体-1表达可被视为口腔恶性肿瘤的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae3/9902024/670450485f43/jomr-13-e3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae3/9902024/670450485f43/jomr-13-e3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae3/9902024/670450485f43/jomr-13-e3-g001.jpg

相似文献

1
Potential Histopathological and Immune Biomarkers in Malignant and Non-Malignant Oral Lesions.恶性和非恶性口腔病变中的潜在组织病理学和免疫生物标志物。
J Oral Maxillofac Res. 2022 Dec 31;13(4):e3. doi: 10.5037/jomr.2022.13403. eCollection 2022 Oct-Dec.
2
Immune checkpoints indoleamine 2,3-dioxygenase 1 and programmed death-ligand 1 in oral mucosal dysplasia.口腔黏膜异型增生中的免疫检查点吲哚胺 2,3-双加氧酶 1 和程序性死亡配体 1。
J Oral Pathol Med. 2018 Sep;47(8):773-780. doi: 10.1111/jop.12737. Epub 2018 Jun 20.
3
Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: A retrospective cohort study.吸烟状况和程序性死亡配体 1 表达对口腔白斑微环境和恶性转化的影响:一项回顾性队列研究。
PLoS One. 2021 Apr 16;16(4):e0250359. doi: 10.1371/journal.pone.0250359. eCollection 2021.
4
Assessment of Oral Lesions With Tobacco Usage: A Cross-Sectional Clinicopathological Study in Sri Ganganagar, Rajasthan, India.烟草使用与口腔病变的评估:印度拉贾斯坦邦斯利甘加纳格尔的一项横断面临床病理研究。
Cureus. 2023 Jan 5;15(1):e33428. doi: 10.7759/cureus.33428. eCollection 2023 Jan.
5
Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions.程序性死亡配体1(PD-L1)表达与肿瘤微环境:对口腔癌前病变患者的意义
Oral Oncol. 2017 May;68:36-43. doi: 10.1016/j.oraloncology.2017.03.006. Epub 2017 Mar 18.
6
Another oral cancer clinical guideline - but does it propose changes to dental practice?又一份口腔癌临床指南——但它会对牙科诊疗实践提出改变建议吗?
Evid Based Dent. 2019 Mar;20(1):7-8. doi: 10.1038/s41432-019-0005-x.
7
Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx.p-16、Ki-67和p-53标志物在口腔和口咽发育异常及恶性病变中的表达
J Oral Maxillofac Pathol. 2019 May-Aug;23(2):224-230. doi: 10.4103/jomfp.JOMFP_299_18.
8
Comparative accuracy of different members of the dental team in detecting malignant and non-malignant oral lesions.牙科团队不同成员在检测口腔恶性和非恶性病变方面的比较准确性。
Br Dent J. 2015 May 8;218(9):525-9. doi: 10.1038/sj.bdj.2015.344.
9
Canine and Feline Oral Cavity Tumours and Tumour-like Lesions: a Retrospective Study of 486 Cases (2015-2017).犬猫口腔肿瘤及肿瘤样病变:486例病例的回顾性研究(2015 - 2017年)
J Comp Pathol. 2019 Oct;172:80-87. doi: 10.1016/j.jcpa.2019.09.007. Epub 2019 Oct 18.
10
Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics.口腔癌前病变的预后:临床、组织病理学及分子生物学特征的意义
Crit Rev Oral Biol Med. 2003;14(1):47-62. doi: 10.1177/154411130301400105.

引用本文的文献

1
Investigating Tumor-Infiltrating Lymphocytes in the Microenvironment of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorders (OPMDs): Can They Shift Our Perspective? A Scoping Review.口腔鳞状细胞癌(OSCC)和口腔潜在恶性疾病(OPMDs)微环境中肿瘤浸润淋巴细胞的研究:它们能改变我们的观点吗?一项范围综述
J Clin Med. 2025 Jan 18;14(2):606. doi: 10.3390/jcm14020606.
2
Diagnostic Utility of Immunofluorescence in Oral Lesions: a Systematic Review.免疫荧光在口腔病变中的诊断效用:一项系统评价
J Oral Maxillofac Res. 2024 Sep 30;15(3):e2. doi: 10.5037/jomr.2024.15302. eCollection 2024 Jul-Sep.
3
Salivary metabolomic identification of biomarker candidates for oral melanoma and oral squamous cell carcinoma in dogs.

本文引用的文献

1
Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma.日光性唇炎和下唇鳞状细胞癌微环境中 PD-L1、CD4+ 和 CD8+ 细胞浸润及肿瘤浸润淋巴细胞(TILs)的免疫表达。
J Appl Oral Sci. 2022 Feb 21;30:e20210344. doi: 10.1590/1678-7757-2021-0344. eCollection 2022.
2
PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma.PD-L1 表达和 CD8+ 淋巴细胞的高肿瘤浸润可预测口咽鳞状细胞癌患者的结局。
Int J Mol Sci. 2020 Jul 23;21(15):5228. doi: 10.3390/ijms21155228.
3
唾液代谢组学鉴定犬口腔黑色素瘤和口腔鳞状细胞癌的生物标志物候选物。
J Vet Intern Med. 2024 Jul-Aug;38(4):2293-2304. doi: 10.1111/jvim.17092. Epub 2024 May 4.
Basal and LPS-stimulated inflammatory markers and the course of individual symptoms of depression.
基础和 LPS 刺激的炎症标志物与抑郁症个体症状的病程。
Transl Psychiatry. 2020 Jul 15;10(1):235. doi: 10.1038/s41398-020-00920-4.
4
Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study.口腔病变进展为口腔鳞状细胞癌中 PD-1 和 PD-L1 的表达增加:一项初步研究。
Sci Rep. 2020 Jun 16;10(1):9705. doi: 10.1038/s41598-020-66257-6.
5
Benign tumours and tumour-like lesions in the oral cavity: a retrospective analysis.口腔良性肿瘤及肿瘤样病变:一项回顾性分析
Postepy Dermatol Alergol. 2019 Dec;36(6):744-751. doi: 10.5114/ada.2018.78805. Epub 2018 Oct 10.
6
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).癌症免疫治疗学会关于免疫治疗头颈部鳞状细胞癌(HNSCC)的共识声明。
J Immunother Cancer. 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5.
7
Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma.生物标志物:口腔鳞状细胞癌个体化精准医学之路上的铺路石。
BMC Cancer. 2018 Sep 21;18(1):911. doi: 10.1186/s12885-018-4806-7.
8
Oral inflammation promotes oral squamous cell carcinoma invasion.口腔炎症促进口腔鳞状细胞癌侵袭。
Oncotarget. 2018 Jun 26;9(49):29047-29063. doi: 10.18632/oncotarget.25540.
9
IFN-γ and other serum cytokines in head and neck squamous cell carcinomas.头颈部鳞状细胞癌中的干扰素-γ及其他血清细胞因子
Acta Otorhinolaryngol Ital. 2018 Apr;38(2):94-102. doi: 10.14639/0392-100X-1530.
10
World Health Organization 4th edition of head and neck tumor classification: insight into the consequential modifications.世界卫生组织头颈部肿瘤分类第4版:对相应修改的见解。
Virchows Arch. 2018 Mar;472(3):311-313. doi: 10.1007/s00428-018-2320-6. Epub 2018 Feb 15.